£3.3M
The investment was led by Whiterock with participation from regional funds and angel backers.
Digital biomarker platform provider for neuroscience clinical trials and patient monitoring.
Cumulus Neuroscience develops digital biomarker platforms and dry sensor EEG headsets to advance neuroscience clinical trials and patient care.
Ronan Cunningham
CEO
Ronan brings executive and innovation leadership experience, having served as CEO of Cumulus Neuroscience and Director of Innovation at DCU Innovate. He also contributes to the sector as a board member at Neuranics and through independent strategic advisory roles.
LinkedInTina Sampath
Chief Executive
The investment was led by Whiterock with participation from regional funds and angel backers.
The financing round was led by the Dementia Discovery Fund with backing from LifeArc and the UK Future Fund.